Page Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 4, 2025, 5:18 pm

Competitors of Page Industries Ltd

All Competitor Stocks of Page Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:45 am

Below is a detailed analysis of the quarterly data for Page Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,317.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,098.00 Cr. (Mar 2025) to 1,317.00 Cr., marking an increase of 219.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,022.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 863.00 Cr. (Mar 2025) to 1,022.00 Cr., marking an increase of 159.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 295.00 Cr.. The value appears strong and on an upward trend. It has increased from 235.00 Cr. (Mar 2025) to 295.00 Cr., marking an increase of 60.00 Cr..
• For OPM %, as of Jun 2025, the value is 22.00%. The value appears strong and on an upward trend. It has increased from 21.00% (Mar 2025) to 22.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 27.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Mar 2025) to 27.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 270.00 Cr.. The value appears strong and on an upward trend. It has increased from 219.00 Cr. (Mar 2025) to 270.00 Cr., marking an increase of 51.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 164.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 37.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 180.03. The value appears strong and on an upward trend. It has increased from 147.04 (Mar 2025) to 180.03, marking an increase of 32.99.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:42 am

Growth

Last Updated: September 5, 2025, 12:05 pm

Balance Sheet

Last Updated: June 16, 2025, 11:35 am

Below is a detailed analysis of the balance sheet data for Page Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,396.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,586.00 Cr. (Mar 2024) to 1,396.00 Cr., marking a decrease of 190.00 Cr..
• For Borrowings, as of Mar 2025, the value is 262.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 185.00 Cr. (Mar 2024) to 262.00 Cr., marking an increase of 77.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 974.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 901.00 Cr. (Mar 2024) to 974.00 Cr., marking an increase of 73.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,643.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,683.00 Cr. (Mar 2024) to 2,643.00 Cr., marking a decrease of 40.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 758.00 Cr.. The value appears strong and on an upward trend. It has increased from 488.00 Cr. (Mar 2024) to 758.00 Cr., marking an increase of 270.00 Cr..
• For CWIP, as of Mar 2025, the value is 72.00 Cr.. The value appears to be declining and may need further review. It has decreased from 239.00 Cr. (Mar 2024) to 72.00 Cr., marking a decrease of 167.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,813.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,956.00 Cr. (Mar 2024) to 1,813.00 Cr., marking a decrease of 143.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,643.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,683.00 Cr. (Mar 2024) to 2,643.00 Cr., marking a decrease of 40.00 Cr..

Notably, the Reserves (1,396.00 Cr.) exceed the Borrowings (262.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Page Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 653.71. This value is within the healthy range. It has increased from 510.31 (Mar 24) to 653.71, marking an increase of 143.40.
• For Diluted EPS (Rs.), as of Mar 25, the value is 653.71. This value is within the healthy range. It has increased from 510.31 (Mar 24) to 653.71, marking an increase of 143.40.
• For Cash EPS (Rs.), as of Mar 25, the value is 742.66. This value is within the healthy range. It has increased from 591.73 (Mar 24) to 742.66, marking an increase of 150.93.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,261.61. It has decreased from 1,431.71 (Mar 24) to 1,261.61, marking a decrease of 170.10.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,261.61. It has decreased from 1,431.71 (Mar 24) to 1,261.61, marking a decrease of 170.10.
• For Dividend / Share (Rs.), as of Mar 25, the value is 900.00. This value exceeds the healthy maximum of 3. It has increased from 370.00 (Mar 24) to 900.00, marking an increase of 530.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 4,424.34. It has increased from 4,107.65 (Mar 24) to 4,424.34, marking an increase of 316.69.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1,007.88. This value is within the healthy range. It has increased from 799.91 (Mar 24) to 1,007.88, marking an increase of 207.97.
• For PBIT / Share (Rs.), as of Mar 25, the value is 918.91. This value is within the healthy range. It has increased from 718.48 (Mar 24) to 918.91, marking an increase of 200.43.
• For PBT / Share (Rs.), as of Mar 25, the value is 877.33. This value is within the healthy range. It has increased from 678.23 (Mar 24) to 877.33, marking an increase of 199.10.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 653.70. This value is within the healthy range. It has increased from 510.30 (Mar 24) to 653.70, marking an increase of 143.40.
• For PBDIT Margin (%), as of Mar 25, the value is 22.78. This value is within the healthy range. It has increased from 19.47 (Mar 24) to 22.78, marking an increase of 3.31.
• For PBIT Margin (%), as of Mar 25, the value is 20.76. This value exceeds the healthy maximum of 20. It has increased from 17.49 (Mar 24) to 20.76, marking an increase of 3.27.
• For PBT Margin (%), as of Mar 25, the value is 19.82. This value is within the healthy range. It has increased from 16.51 (Mar 24) to 19.82, marking an increase of 3.31.
• For Net Profit Margin (%), as of Mar 25, the value is 14.77. This value exceeds the healthy maximum of 10. It has increased from 12.42 (Mar 24) to 14.77, marking an increase of 2.35.
• For Return on Networth / Equity (%), as of Mar 25, the value is 51.81. This value is within the healthy range. It has increased from 35.64 (Mar 24) to 51.81, marking an increase of 16.17.
• For Return on Capital Employeed (%), as of Mar 25, the value is 62.78. This value is within the healthy range. It has increased from 45.94 (Mar 24) to 62.78, marking an increase of 16.84.
• For Return On Assets (%), as of Mar 25, the value is 27.58. This value is within the healthy range. It has increased from 21.21 (Mar 24) to 27.58, marking an increase of 6.37.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.85. It has increased from 1.70 (Mar 24) to 1.85, marking an increase of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.00 (Mar 24) to 1.72, marking a decrease of 0.28.
• For Quick Ratio (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 24) to 0.87, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.84. This value is within the healthy range. It has increased from 0.81 (Mar 24) to 4.84, marking an increase of 4.03.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 125.43. This value exceeds the healthy maximum of 50. It has increased from 60.74 (Mar 24) to 125.43, marking an increase of 64.69.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 110.41. This value exceeds the healthy maximum of 50. It has increased from 52.38 (Mar 24) to 110.41, marking an increase of 58.03.
• For Earning Retention Ratio (%), as of Mar 25, the value is -25.43. This value is below the healthy minimum of 40. It has decreased from 39.26 (Mar 24) to -25.43, marking a decrease of 64.69.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is -10.41. This value is below the healthy minimum of 40. It has decreased from 47.62 (Mar 24) to -10.41, marking a decrease of 58.03.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 24.24. This value is within the healthy range. It has increased from 19.87 (Mar 24) to 24.24, marking an increase of 4.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.72. This value is within the healthy range. It has increased from 13.68 (Mar 24) to 16.72, marking an increase of 3.04.
• For Enterprise Value (Cr.), as of Mar 25, the value is 47,230.15. It has increased from 38,079.89 (Mar 24) to 47,230.15, marking an increase of 9,150.26.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.57. This value exceeds the healthy maximum of 3. It has increased from 8.31 (Mar 24) to 9.57, marking an increase of 1.26.
• For EV / EBITDA (X), as of Mar 25, the value is 42.01. This value exceeds the healthy maximum of 15. It has decreased from 42.68 (Mar 24) to 42.01, marking a decrease of 0.67.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.67. This value exceeds the healthy maximum of 3. It has increased from 8.38 (Mar 24) to 9.67, marking an increase of 1.29.
• For Retention Ratios (%), as of Mar 25, the value is -25.43. This value is below the healthy minimum of 30. It has decreased from 39.25 (Mar 24) to -25.43, marking a decrease of 64.68.
• For Price / BV (X), as of Mar 25, the value is 33.90. This value exceeds the healthy maximum of 3. It has increased from 24.05 (Mar 24) to 33.90, marking an increase of 9.85.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.67. This value exceeds the healthy maximum of 3. It has increased from 8.38 (Mar 24) to 9.67, marking an increase of 1.29.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness